Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia

NCT00498004 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT00498004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00498004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia
Lead sponsor
Inje University
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2007
Completion date
September 30, 2008
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia